SteadyMed is on the Cruelty Free Investing use of animals list because they use animals for drug testing and clinical trials.
The company stated in the following report that they conduct pre-clinical trials of their drugs on animals.
“Formulations representative of Trevyent and Remodulin were tested in an animal model via continuous subcutaneous infusion for 7 days.” Read the following document
SteadyMed Ltd. is a specialty pharmaceutical company. The Company is focused on the development and commercialization of various therapeutic product candidates. Its primary focus is to obtain approval in the United States for the sale of Trevyent for the treatment of pulmonary arterial hypertension (PAH). [Source: Reuters]
Company Website: http://www.steadymed.com